Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

SYMPTOM-BASED CLUSTERING OF MEN IN THE SYMPTOMS OF LOWER URINARY TRACT DYSFUNCTION RESEARCH NETWORK (LURN) OBSERVATIONAL COHORT STUDY.

Liu G, Andreev VP, Helmuth ME, Yang CC, Lai HH, Smith AR, Wiseman JB, Merion RM, Erickson BA, Cella D, Griffith JW, Gore JL, DeLancey JOL, Kirkali Z; LURN Study Group.

J Urol. 2019 May 23:101097JU0000000000000354. doi: 10.1097/JU.0000000000000354. [Epub ahead of print]

PMID:
31120372
2.

Life and expectations post-kidney transplant: a qualitative analysis of patient responses.

Tucker EL, Smith AR, Daskin MS, Schapiro H, Cottrell SM, Gendron ES, Hill-Callahan P, Leichtman AB, Merion RM, Gill SJ, Maass KL.

BMC Nephrol. 2019 May 16;20(1):175. doi: 10.1186/s12882-019-1368-0.

3.

Comparison of patient and provider goals, expectations, and experiences following kidney transplantation.

Maass KL, Smith AR, Tucker EL, Schapiro H, Cottrell SM, Gendron E, Hill-Callahan P, Gill SJ, Daskin MS, Merion RM, Leichtman AB.

Patient Educ Couns. 2019 May;102(5):990-997. doi: 10.1016/j.pec.2018.12.010. Epub 2018 Dec 13.

PMID:
30591284
4.

Symptom Based Clustering of Women in the LURN Observational Cohort Study.

Andreev VP, Liu G, Yang CC, Smith AR, Helmuth ME, Wiseman JB, Merion RM, Weinfurt KP, Cameron AP, Lai HH, Cella D, Gillespie BW, Helfand BT, Griffith JW, DeLancey JOL, Fraser MO, Clemens JQ, Kirkali Z; LURN Study Group.

J Urol. 2018 Dec;200(6):1323-1331. doi: 10.1016/j.juro.2018.06.068. Epub 2018 Jul 7.

PMID:
29990467
5.

Return on investment for financial assistance for living kidney donors in the United States.

Mathur AK, Xing J, Dickinson DM, Warren PH, Gifford KA, Hong BA, Ojo A, Merion RM.

Clin Transplant. 2018 Jul;32(7):e13277. doi: 10.1111/ctr.13277. Epub 2018 Jun 3.

PMID:
29740879
6.

Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary Incontinence.

Siddiqui NY, Wiseman JB, Cella D, Bradley CS, Lai HH, Helmuth ME, Smith AR, Griffith JW, Amundsen CL, Kenton KS, Clemens JQ, Kreder KJ, Merion RM, Kirkali Z, Kusek JW, Cameron AP; LURN.

J Urol. 2018 Oct;200(4):848-855. doi: 10.1016/j.juro.2018.04.076. Epub 2018 May 3.

7.

Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence.

Cameron AP, Smith AR, Lai HH, Bradley CS, Liu AB, Merion RM, Gillespie BW, Amundsen CL, Cella D, Griffith JW, Wiseman JB, Kreder KJ, Kenton KS, Helmuth ME, Fraser MO, Clemens JQ, Kirkali Z, Kusek JW, Siddiqui NY; LURN Study Group.

Neurourol Urodyn. 2018 Nov;37(8):2586-2596. doi: 10.1002/nau.23587. Epub 2018 Apr 10.

8.

Kidney transplant graft outcomes in 379 257 recipients on 3 continents.

Merion RM, Goodrich NP, Johnson RJ, McDonald SP, Russ GR, Gillespie BW, Collett D.

Am J Transplant. 2018 Aug;18(8):1914-1923. doi: 10.1111/ajt.14694. Epub 2018 Mar 24.

PMID:
29573328
9.

Estimating the effect of a rare time-dependent treatment on the recurrent event rate.

Smith AR, Zhu D, Goodrich NP, Merion RM, Schaubel DE.

Stat Med. 2018 May 30;37(12):1986-1996. doi: 10.1002/sim.7626. Epub 2018 Feb 26.

10.

Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.

Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM.

Liver Transpl. 2017 Dec;23(12):1519-1530. doi: 10.1002/lt.24872.

11.

Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.

Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, Burton JR Jr, Terrault NA, Fox AN, DiMartini AF.

Transplantation. 2018 Jan;102(1):105-118. doi: 10.1097/TP.0000000000001942.

12.

Reasons for Seeking Clinical Care for Lower Urinary Tract Symptoms: A Mixed Methods Study.

Griffith JW, Messersmith EE, Gillespie BW, Wiseman JB, Flynn KE, Kirkali Z, Kusek JW, Bavendam T, Cella D, Kreder KJ, Nero JJ, Corona ME, Bradley CS, Kenton KS, Helfand BT, Merion RM, Weinfurt KP; LURN Study Group.

J Urol. 2018 Feb;199(2):528-535. doi: 10.1016/j.juro.2017.07.067. Epub 2017 Jul 20.

13.

National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.

Sharma P, Goodrich NP, Schaubel DE, Smith AR, Merion RM.

Liver Transpl. 2017 Sep;23(9):1143-1152. doi: 10.1002/lt.24813.

14.

Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.

Emond JC, Goodrich NP, Pomposelli JJ, Baker TB, Humar A, Grant DR, Abt P, Friese CE, Fisher RA, Kam I, Sherker AH, Gillespie BW, Merion RM.

Transplantation. 2017 Oct;101(10):2375-2384. doi: 10.1097/TP.0000000000001823.

15.

The National Living Donor Assistance Center perspective on barriers to the use of federal travel grants for living donors.

Mathur AK, Hong B, Ojo A, Merion RM.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12984. Epub 2017 May 9.

PMID:
28485106
16.

Evidence of the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review.

Bradley CS, Erickson BA, Messersmith EE, Pelletier-Cameron A, Lai HH, Kreder KJ, Yang CC, Merion RM, Bavendam TG, Kirkali Z; Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).

J Urol. 2017 Nov;198(5):1010-1020. doi: 10.1016/j.juro.2017.04.097. Epub 2017 May 4.

17.

HLA Amino Acid Polymorphisms and Kidney Allograft Survival.

Kamoun M, McCullough KP, Maiers M, Fernandez Vina MA, Li H, Teal V, Leichtman AB, Merion RM.

Transplantation. 2017 May;101(5):e170-e177. doi: 10.1097/TP.0000000000001670.

18.

Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.

Levitsky J, Goldberg D, Smith AR, Mansfield SA, Gillespie BW, Merion RM, Lok AS, Levy G, Kulik L, Abecassis M, Shaked A.

Clin Gastroenterol Hepatol. 2017 Apr;15(4):584-593.e2. doi: 10.1016/j.cgh.2016.07.035. Epub 2016 Aug 25.

19.

Misclassification Errors in Unsupervised Classification Methods. Comparison Based on the Simulation of Targeted Proteomics Data.

Andreev VP, Gillespie BW, Helfand BT, Merion RM.

J Proteomics Bioinform. 2016;Suppl 14. pii: 005. Epub 2016 May 16.

20.

National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation.

Goodrich NP, Schaubel DE, Smith AR, Merion RM, Sharma P.

Transplantation. 2016 Oct;100(10):2115-21. doi: 10.1097/TP.0000000000001348.

21.

Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.

Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.

Liver Transpl. 2016 Sep;22(9):1214-22. doi: 10.1002/lt.24496. Epub 2016 Aug 2.

22.

Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.

Pomposelli JJ, Goodrich NP, Emond JC, Humar A, Baker TB, Grant DR, Fisher RA, Roberts JP, Olthoff KM, Gillespie BW, Merion RM.

Transplantation. 2016 Jul;100(7):1490-9. doi: 10.1097/TP.0000000000001240.

23.

Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.

Dew MA, DiMartini AF, Ladner DP, Simpson MA, Pomfret EA, Gillespie BW, Merion RM, Zee J, Smith AR, Holtzman S, Sherker AH, Weinrieb R, Fisher RA, Emond JC, Freise CE, Burton JR Jr, Butt Z.

Transplantation. 2016 Jun;100(6):1257-69. doi: 10.1097/TP.0000000000001144.

24.

Symptoms of Lower Urinary Tract Dysfunction Research Network.

Yang CC, Weinfurt KP, Merion RM, Kirkali Z; LURN Study Group.

J Urol. 2016 Jul;196(1):146-52. doi: 10.1016/j.juro.2016.01.007. Epub 2016 Jan 16.

25.

Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.

Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion RM.

Am J Transplant. 2016 Feb;16(2):594-602. doi: 10.1111/ajt.13479. Epub 2015 Oct 13.

26.

Defining long-term outcomes with living donor liver transplantation in North America.

Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.

Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.

27.

Serum sodium and survival benefit of liver transplantation.

Sharma P, Schaubel DE, Goodrich NP, Merion RM.

Liver Transpl. 2015 Mar;21(3):308-13. doi: 10.1002/lt.24063. Epub 2015 Feb 10.

28.

Changes in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).

Emond JC, Fisher RA, Everson G, Samstein B, Pomposelli JJ, Zhao B, Forney S, Olthoff KM, Baker TB, Gillespie BW, Merion RM.

Liver Transpl. 2015 Feb;21(2):151-61. doi: 10.1002/lt.24062.

29.

Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).

Ladner DP, Dew MA, Forney S, Gillespie BW, Brown RS Jr, Merion RM, Freise CE, Hayashi PH, Hong JC, Ashworth A, Berg CL, Burton JR Jr, Shaked A, Butt Z.

J Hepatol. 2015 Feb;62(2):346-53. doi: 10.1016/j.jhep.2014.08.043. Epub 2014 Sep 6.

30.

Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes.

Messersmith EE, Gross CR, Beil CA, Gillespie BW, Jacobs C, Taler SJ, Merion RM, Jowsey SG, Leichtman AB, Hong BA; RELIVE Study Group.

Transplantation. 2014 Dec 27;98(12):1294-300. doi: 10.1097/TP.0000000000000360.

31.

Morbidity and mortality of live lung donation: results from the RELIVE study.

Yusen RD, Hong BA, Messersmith EE, Gillespie BW, Lopez BM, Brown KL, Odim J, Merion RM, Barr ML; RELIVE Study Group.

Am J Transplant. 2014 Aug;14(8):1846-52.

32.

Tool value: the liver donor risk index 8 years on.

Merion RM.

Liver Transpl. 2014 Jul;20(7):751-2. doi: 10.1002/lt.23920. No abstract available.

33.

Variation in access to the liver transplant waiting list in the United States.

Mathur AK, Ashby VB, Fuller DS, Zhang M, Merion RM, Leichtman A, Kalbfleisch J.

Transplantation. 2014 Jul 15;98(1):94-9. doi: 10.1097/01.TP.0000443223.89831.85.

34.

Development of the National Living Donor Assistance Center: reducing financial disincentives to living organ donation.

Warren PH, Gifford KA, Hong BA, Merion RM, Ojo AO.

Prog Transplant. 2014 Mar;24(1):76-81. doi: 10.7182/pit2014593.

35.

Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.

Salgia RJ, Goodrich NP, Simpson H, Merion RM, Sharma P.

Dig Dis Sci. 2014 Aug;59(8):1976-82. doi: 10.1007/s10620-014-3065-y. Epub 2014 Feb 21.

36.

Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex.

Mathur AK, Schaubel DE, Zhang H, Guidinger MK, Merion RM.

Transplantation. 2014 Apr 27;97(8):862-9. doi: 10.1097/01.tp.0000438634.44461.67.

37.

Patient-specific prediction of ESRD after liver transplantation.

Sharma P, Goodrich NP, Schaubel DE, Guidinger MK, Merion RM.

J Am Soc Nephrol. 2013 Dec;24(12):2045-52. doi: 10.1681/ASN.2013040436. Epub 2013 Sep 12.

38.

Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study.

Gross CR, Messersmith EE, Hong BA, Jowsey SG, Jacobs C, Gillespie BW, Taler SJ, Matas AJ, Leichtman A, Merion RM, Ibrahim HN; RELIVE Study Group.

Am J Transplant. 2013 Nov;13(11):2924-34. doi: 10.1111/ajt.12434. Epub 2013 Sep 6.

39.

Response to "dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference" by Melcher et al.

Ojo AO, Merion RM, Howard DH, Warren PH.

Am J Transplant. 2013 Aug;13(8):2228. doi: 10.1111/ajt.12345. Epub 2013 Jul 8. No abstract available.

40.

Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure.

Volk ML, Roney M, Merion RM.

Liver Transpl. 2013 Sep;19(9):987-90. doi: 10.1002/lt.23683. Epub 2013 Aug 13.

41.

Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.

Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM.

Liver Transpl. 2013 Mar;19(3):259-67. doi: 10.1002/lt.23595.

42.

Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.

Sharma P, Goodrich NP, Zhang M, Guidinger MK, Schaubel DE, Merion RM.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1135-42. doi: 10.2215/CJN.09600912. Epub 2013 Feb 28.

43.

Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades.

Taler SJ, Messersmith EE, Leichtman AB, Gillespie BW, Kew CE, Stegall MD, Merion RM, Matas AJ, Ibrahim HN; RELIVE Study Group.

Am J Transplant. 2013 Feb;13(2):390-8. doi: 10.1111/j.1600-6143.2012.04321.x. Epub 2012 Nov 8.

44.

Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilization.

White SL, Leichtman AB, O'Connor K, Lipkowitz G, Pietroski R, Stoff JS, Luskin RS, Belcher J, Meyer K, Merion RM, Port FK, Delmonico FL.

Transplant Proc. 2012 Sep;44(7):2223-6. doi: 10.1016/j.transproceed.2012.07.103.

PMID:
22974959
45.

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.

Liver Transpl. 2012 Dec;18(12):1456-63. doi: 10.1002/lt.23548.

46.

Comparison of the long-term outcomes of kidney transplantation: USA versus Spain.

Ojo AO, Morales JM, González-Molina M, Steffick DE, Luan FL, Merion RM, Ojo T, Moreso F, Arias M, Campistol JM, Hernandez D, Serón D; Scientific Registry of Transplant Recipients and; Spanish Chronic Allograft Study Group.

Nephrol Dial Transplant. 2013 Jan;28(1):213-20. doi: 10.1093/ndt/gfs287. Epub 2012 Jul 2.

47.

Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors.

Woodside KJ, Merion RM, Leichtman AB, de los Santos R, Arrington CJ, Rao PS, Sung RS.

Am J Transplant. 2012 Aug;12(8):2106-14. doi: 10.1111/j.1600-6143.2012.04146.x. Epub 2012 Jun 15.

48.

Complications of living donor hepatic lobectomy--a comprehensive report.

Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM; A2ALL Study Group.

Am J Transplant. 2012 May;12(5):1208-17. doi: 10.1111/j.1600-6143.2011.03972.x. Epub 2012 Feb 15.

49.

Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.

Sharma P, Welch K, Hussain H, Pelletier SJ, Fontana RJ, Marrero J, Merion RM.

Dig Dis Sci. 2012 Mar;57(3):806-12. doi: 10.1007/s10620-011-1910-9. Epub 2011 Sep 28.

50.

The angel is in the details.

Hirth RA, Merion RM.

J Health Polit Policy Law. 2011 Aug;36(4):757-61. doi: 10.1215/03616878-1334704. No abstract available.

PMID:
21940425

Supplemental Content

Loading ...
Support Center